The best place to discover, build, and manage on-demand life science teams.
Joined August 2015
- Tweets 581
- Following 261
- Followers 190
- Likes 271
180 Photos and videos
Jun 3
Hear Clora CEO @rahulc speak with @AcadiaPharma CEO Catherine Owen Adams about her journey to #biotech #leadership, the future of CNS #innovation, and the forces shaping biotech today. Listen to the full episode.
How do you go from pharmacist to leading a billion-dollar biotech? Catherine Owen Adams, CEO of @AcadiaPharma, joins @rahulc on #Biotech2050 to discuss neuro & rare disease innovation, commercialization, AI, & first-time CEO lessons. 🧠🎙️- on.soundcloud.com/nXJ0ArsZaZ…
22
Apr 28
Our new website is live: ow.ly/m7QU50YOvst
15,000 vetted life sciences consultants. Access in days, not months. Faster than hiring. More flexible than CROs.
#Biotech #LifeSciences
19
Apr 17
Proud to support our client @C4Therapeutics as they advance targeted #proteindegradation. They just announced an expanded long-term partnership with @Roche, highlighting strong momentum behind their platform. Read more:
ow.ly/TEsP50YKvnR
27
Apr 8
Biotech doesn’t have a hiring problem—it has a #resourcing strategy problem.
Only 48% of talent needs are met, while specialized roles take 100 days to fill. Leading companies are rethinking work, bringing in #expertise on demand and prioritizing flexibility to stay on track.
1
47
Apr 3
In #biotech and #pharma, speed has been seen as a tradeoff with quality—but that’s changing. Progress now depends on fast access to the right #expertise. Leading teams use agile #talent models to tap global experts on demand, accelerating timelines without compromising rigor.
19
Mar 20
Which #resourcing model gives you speed, control, and quality? FTEs take 100 days. CROs lack flexibility. See how #consultants deliver expertise without delays. Download our free reports to compare your options: ow.ly/pF9150YvZfA
13
Mar 13
Clora CEO @rahulc speaks with physician-scientist and #biotech founder Sheila Gujrathi, MD, about her path through biotech #leadership, building companies, and the lessons she’s learned along the way. Listen to the #podcast now.
This episode is sponsored by @Quartzy.
Sheila Gujrathi, MD joins @rahulc on #Biotech2050 to discuss leadership, venture building, & lessons from her book The Mirror Effect on confidence, leadership & navigating power in biotech
🎧 on.soundcloud.com/RPVtOCG58w…
#TheMirrorEffect #biotech
1
16
Mar 6
Biotech #IPOs may be making a comeback in 2026. After peaking with 87 U.S. #biotech IPOs in 2021, activity dropped to just 11 in 2025. Now momentum may be returning as more companies begin entering the public markets: ow.ly/fmho50YpNil
10
Feb 27
JPM 2026 signaled renewed optimism for #biopharma. Deals are expected to center on late-stage pipelines/assets, while R&D priorities move toward more prevalent diseases over rare/orphan indications. Read more from @BioSpace: ow.ly/Q5Cz50YlbFC
8
Feb 18
.@bainalerts highlights 4 trends reshaping deal strategy: vertical integration for speed and control, next-gen obesity assets, continued momentum in ADCs, & growing cross-border opportunity in Greater China. Differentiation—not scale—is driving M&A: ow.ly/UOMK50Yfmp9
15
Jan 28
Biopharma leaders from @Perspective_Tx, @LineageCell and Catalyst #Pharma are optimistic about 2026. Investment is returning, #science is strong, and momentum is building after a tough 2025. Read more from @FiercePharma: fiercepharma.com/pharma/fier…
1
9
Jan 22
Big congrats to our client, Parabilis Medicines, on closing a $305M Series F to advance their Helicon™ medicines, including a Phase 3 trial for FOG-001 in desmoid tumors. A big move in targeting tough-to-treat cancers. Read more in their press release: ow.ly/9XNy50Y0BOi
1
48
Jan 14
We’re proud to support our client as Somite becomes @CellularIntelHQ, building the first universal virtual cell-signaling model to guide, not just map, #biology. A bold step toward predictive, programmable #cellbehavior.
Somite is now Cellular Intelligence.
More than a rebrand, this reflects what our team has been building over the last two years: the first universal virtual cell signaling model, designed to understand, predict, and ultimately control cell behavior.
To further mark this step forward, we’re releasing a new white paper that shares our technical progress and maps out what is to come: cellularintelligence.com/sci…
Deeply proud of our team for daring to turn an implausible idea into reality. Dive into what we’re creating at @CellularIntelHQ today: cellularintelligence.com/
21
Jan 9
Will you be in the Bay Area for #JPM2026 next week?
Our CEO @rahulc will be there and would love to connect. Learn how #Clora is helping #lifesciences companies advance programs faster without the long-term cost of traditional #hiring.
Drop a comment to set up a meeting!
2
79
23 Dec 2025
As we close out the year, we want to extend our gratitude to the life science professionals and companies we’ve had the privilege to work with.
Thank you for making 2025 a year of innovation, collaboration, and growth.
Wishing you a joyful holiday season and a Happy New Year.
17
9 Dec 2025
New @Biotech2050Pod episode: Clora CEO @rahulc talks with John Lepore, CEO of @ProFoundTx, on leading in #biotech, uncovering the human proteome, and using #AI to unlock new drug targets. A look into the next frontier of #medicine. Listen using the link below.
4 Dec 2025
The episode is sponsored by @Quartzy.
🔬 “What if we’ve only mapped a fraction of human proteins?”
@rahulc interviews John Lepore, CEO of @ProFoundTx, on AI, risk-taking, & the next frontier of first-in-class medicines powered by the expanded proteome.
🎧 on.soundcloud.com/xmG2cQ8FBp…
14
3 Dec 2025
Biotech VC funding jumped 70.9% in Q3 2025, from $1.8B to $3.1B. Series D saw the biggest leap, up nearly 60x to $832M, a strong signal of renewed investor confidence amid ongoing challenges. Read more: ow.ly/3atQ50XzZYS
#biotech #venturecapital #biotechfunding
13
21 Nov 2025
.@pfizer's $10B deal to acquire @MetseraInc is a major #biotech M&A move, signaling renewed #bigpharma investment. Despite ongoing industry challenges, momentum in M&A and licensing is building. Read more: ow.ly/fifz50Xt0Fo
24
11 Nov 2025
🎙️ @JTananbaum, CEO of @ForesiteCapital, joins Clora CEO @rahulc to explore #biotech innovation, #AI in #drugdiscovery, and investing through market cycles. A must-listen on strategy, #science, and impact. Listen using the link below.
6 Nov 2025
💸 Interest rates 🤖 AI 🧠Human insight
All shaping the future of biotech.
🎙️ @JTananbaum, Founder & CEO of @foresitecapital, joins @rahulc on #Biotech2050 to unpack venture cycles, AI’s rise in drug discovery, & next wave of innovation.
🎧 Listen now →on.soundcloud.com/QtQ8QCZskz…
15